First Horizon Advisors, Inc. Sarepta Therapeutics, Inc. Transaction History
First Horizon Advisors, Inc.
- $3.81 Billion
- Q2 2025
A detailed history of First Horizon Advisors, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 221 shares of SRPT stock, worth $4,037. This represents 0.0% of its overall portfolio holdings.
Number of Shares
221
Previous 268
17.54%
Holding current value
$4,037
Previous $17,000
82.35%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding SRPT
# of Institutions
481Shares Held
91.1MCall Options Held
1.39MPut Options Held
1.15M-
Black Rock Inc. New York, NY10.3MShares$189 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$167 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$166 Million0.12% of portfolio
-
State Street Corp Boston, MA4.07MShares$74.3 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$61.5 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.6B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...